| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |